FAIM
AMGN icon

Financial Advocates Investment Management’s Amgen AMGN Stock Holding History

Financial Advocates Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$156K – 771
2024
Q2 		$156K Buy
+500
New +$147K 0.01% 687

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Financial Advocates Investment Management's AMGN Position: Q3 2025 in Review

Financial Advocates Investment Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 2,865 shares — an estimated $800K sold.

Financial Advocates Investment Management first reported a position in AMGN in Q4 2017 and held it in 31 quarters. The position peaked at $4.96M in Q3 2024. 2,821 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Financial Advocates Investment Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 2,865 Amgen shares in Q3 2025, an estimated $800K.
  • Financial Advocates Investment Management first reported a position in Amgen in Q4 2017 and held it in 31 quarters.
  • Financial Advocates Investment Management's Amgen position peaked at $4.96M in Q3 2024.
  • 2,821 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Financial Advocates Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.